Skip to main content
JADPRO Live 2025 Main banner
Icon Legend
Presentation Icons
CE Credit Available
CE Credit Available
Poster Presentation
Poster Presentation
Pharmacology Credit Available
Pharmacology Credit Available
Surgical Oncology
Surgical Oncology
Radiation Oncology
Radiation Oncology
Ticketed Session - Additional Fee
Ticketed Session - Additional Fee
Capturing for On Demand
Capturing for On Demand
Ticketed Event - Included w. Registration
Ticketed Event - Included w. Registration

Full Schedule

  1. Home
  2. Full Schedule

Full Schedule

  • Thursday, October 23, 2025
  • 7:30 AM - 9:00 AM ET

    Independent CE Breakfast Satellite Symposium:
    Cases in the Clinic: Aligning Your Practice to the Evolution of HR-Positive Metastatic Breast Cancer Care
  • 7:30 AM - 7:00 PM ET
    Conference Registration
  • 8:00 AM - 12:00 PM ET
    Exhibitor Registration & Lead Retrieval
  • 9:00 AM - 10:30 AM ET
    Independent CE Satellite Symposium:
    Oncolytic Therapy for Melanoma: Hands-On Training
  • 11:00 AM - 12:30 PM ET
    Independent CE Satellite Symposium:
    Oncolytic Therapy for Melanoma: Hands-On Training (Repeat of 9:00 am Session)
  • 11:00 AM - 3:00 PM ET
    Braindate
  • 12:00 PM - 1:30 PM ET
    Independent CE Lunch Satellite Symposium:
    Advancing to the Next Level of Care With Bispecific Antibodies in R/R FL and R/R DLBCL
  • 1:00 PM - 3:00 PM ET
    Pre-Conference Session
    Advances in Cancer Immunotherapy (ACI): Managing Multi-Organ Toxicities Associated With Cell Therapies and Immune Checkpoint Inhibitors
    Collaboration between Society for Immunotherapy in Cancer (SITC) & APSHO
  • 1:00 PM - 3:00 PM ET
    Pre-Conference Workshop: Hands-On Procedure Training
    (Bone Marrow Aspiration, Lumbar Puncture, and Ommaya Reservoir Access)
  • 2:00 PM - 3:00 PM ET
    Independent CE Satellite Symposium: Non-Small Cell Lung Cancer: Updates on Molecular Diagnostics, Targeted Treatment, and Adverse Event Management for Optimized Patient Outcomes
  • 2:45 PM - 3:30 PM ET
    Refreshment Break
  • 3:00 PM - 4:00 PM ET
    Non-CE Satellite Symposium: Evolving Strategies for Locally Advanced or Metastatic EGFR-mutated NSCLC and HR+/HER2– (IHC 0, IHC 1+, IHC 2+/ISH–) mBC
    AstraZeneca
  • 3:00 PM - 4:00 PM ET
    Non-CE Satellite Symposium: Navigating Adverse Reactions To Help Manage Standard-of-Care Treatment For Patients With la/mUC
    Astellas Pharma & Pfizer Oncology
  • 3:00 PM - 4:00 PM ET
    Non-CE Satellite Symposium: Partnering to Deliver Continuity of Care with Elrexfio (A BCMA-Directed Bispecific Immunotherapy for Certain Adult Patients With Relapsed or Refractory Multiple Myeloma)
    Pfizer, Inc.
  • 4:00 PM - 4:45 PM ET
    Navigating Rapid Advancement in Cancer Care: The APP Impact
    Supported by Johnson & Johnson
  • 4:00 PM - 6:00 PM ET
    Pre-Conference Seminar: Addressing Psychological Burdens Throughout the Continuum of Care
  • 4:00 PM - 6:00 PM ET
    Pre-Conference Workshop: Hands-On Procedure Training
    (Bone Marrow Aspiration, Lumbar Puncture, and Ommaya Reservoir Access)

    (Repeat of 1:00 pm Session)
  • 5:00 PM - 5:45 PM ET
    APSHO Annual Member Meeting
  • 6:00 PM - 7:00 PM ET
    Rare Disease Reception: Systemic Mastocytosis
    Supported by Blueprint Medicines
  • 6:00 PM - 7:00 PM ET
    Rare Disease Reception: Uveal Melanoma
    Supported by Immunocore
  • 7:15 PM - 9:00 PM ET
    Welcome Reception
  • Friday, October 24, 2025
  • 6:30 AM - 4:35 PM ET
    Exhibitor Registration & Lead Retrieval
  • 6:30 AM - 5:30 PM ET
    Conference Registration
  • 7:00 AM - 8:15 AM ET
    Breakfast Activity/Non-CE Satellite Symposium: Redefining Frontline Therapy in Patients with Newly Diagnosed Multiple Myeloma: A Focus on the Outcomes of Transplant-Eligible and Transplant-Ineligible Patients as seen in the PERSEUS and MAIA Trials
    Johnson & Johnson
  • 7:00 AM - 8:15 AM ET
    Breakfast Activity: Non-CE Satellite Symposium: A Treatment Option for Adult Patients With Locally Advanced or Metastatic Urothelial Cancer
    Merck & Co., Inc.
  • 7:00 AM - 8:15 AM ET
    Breakfast Activity: Non-CE Satellite Symposium: Reducing access barriers: New FDA label updates on cell therapy post-treatment monitoring requirements
    Bristol Myers Squibb
  • 7:00 AM - 8:15 AM ET
    Breakfast Activity: Non-CE Satellite Symposium: Supporting Patients With HR+/HER2- mBC Throughout Their Treatment Journey
    Pfizer, Inc.
  • 7:00 AM - 8:20 AM ET
    Exhibit Hall Open &
    Continental Breakfast
  • 7:00 AM - 8:20 AM ET
    Professional Profile Pavilion
  • 8:30 AM - 8:35 AM ET
    Welcome & Opening Remarks
  • 8:30 AM - 9:45 AM ET
    The Power of a Unified Voice: Optimizing the AP Role Through Society Collaborations
  • 9:55 AM - 10:55 AM ET
    A Team-Based Approach to the Management of Acute and Late Radiation Side Effects
  • 9:55 AM - 10:55 AM ET
    Navigating Relapsed/Refractory Multiple Myeloma: Evidence-Based Approaches in a Changing Landscape
  • 9:55 AM - 10:55 AM ET
    New Drug Updates in Solid Tumors
  • 10:00 AM - 4:30 PM ET
    Braindate
  • 11:00 AM - 11:30 AM ET
    APSHO Meet & Greet
    Awards & Recognition Committee
  • 11:00 AM - 12:00 PM ET
    Exhibit Hall Open &
    Refreshment Break
  • 11:00 AM - 12:00 PM ET
    Professional Profile Pavilion
  • 11:05 AM - 11:35 AM ET
    Exhibit Hall Presentation: Exploring the Role of c-Met Protein Overexpression in the NSCLC Treatment Landscape
    AbbVie
  • 11:05 AM - 11:35 AM ET
    Exhibit Hall PresentationTheater: Long Term Monitoring and Transitions of Care after CARVYKTI
    Johnson & Johnson
  • 11:05 AM - 11:50 AM ET
    Exhibit Hall Presentation: Offering TRODELVY for Appropriate Patients With Pretreated HR+/HER2- mBC and mTNBC
    Gilead and Kite Oncology
  • 11:05 AM - 12:00 PM ET
    Moderated Posters
  • 11:30 AM - 12:00 PM ET
    APSHO Meet & Greet:
    Communications Committee
  • 12:10 PM - 12:55 PM ET
    Navigating p16-Positive Oropharyngeal Cancer: A Multidisciplinary Patient-Centered Approach
  • 12:10 PM - 12:55 PM ET
    Novel Therapies and Multidisciplinary Strategies in Metastatic Triple-Positive Breast Cancer
  • 12:10 PM - 12:55 PM ET
    The Lowdown on Low Counts: Navigating Complex Cases in Therapy-Related Cytopenias
  • 1:00 PM - 2:20 PM ET
    Exhibit Hall Open &
    Lunch
  • 1:00 PM - 2:20 PM ET
    Lunch Activity/Non-CE Satellite Symposium: Two First-In-Class Treatments for Patients with Relapsed or Refractory Multiple Myeloma
    Johnson & Johnson
  • 1:00 PM - 2:20 PM ET
    Lunch Activity: Non-CE Satellite Symposium: A 2L Treatment Option for HR+/HER2− aBC or mBC With PIK3CA, AKT1, or PTEN Alterations Following Progression on or After ET ± CDK4/6i
    AstraZeneca
  • 1:00 PM - 2:20 PM ET
    Lunch Activity: Non-CE Satellite Symposium: A Treatment Option for Adults with Certain R/R DLBCL After ≥2 Prior Lines of Systemic Therapy
    Pfizer, Inc.
  • 1:00 PM - 2:20 PM ET
    Lunch Activity: Non-CE Satellite Symposium: Addressing Real-World Clinical Evidence in Polycythemia Vera and Myelofibrosis: Subtitle: A Case-Based Discussion on Clinical Decision Making
    Incyte Corporation
  • 1:00 PM - 2:20 PM ET
    Lunch Activity: Non-CE Satellite Symposium: Alternative Routes of Administration: Advancing Oncology Care with Subcutaneous Immunotherapy
    Bristol Myers Squibb
  • 1:00 PM - 2:20 PM ET
    Professional Profile Pavilion
  • 1:30 PM - 2:00 PM ET
    APSHO Meet & Greet:
    Diversity, Equity, & Inclusion (DEI) Committee
  • 2:00 PM - 2:30 PM ET
    APSHO Meet & Greet:
    Mentor Match Meet Up
  • 2:30 PM - 3:30 PM ET
    KEYNOTE ADDRESS
    Clinician and Kin: United in Care with the Family Caregiver
  • 3:30 PM - 4:00 PM ET
    APSHO Meet & Greet
    Surgical Oncology Committee
  • 3:35 PM - 4:35 PM ET
    Exhibit Hall Open &
    Refreshment Break
  • 3:35 PM - 4:35 PM ET
    Professional Profile Pavilion
  • 3:40 PM - 4:10 PM ET
    Exhibit Hall Presentation Theater: Collaborative Melanoma Care: Informing Decisions and Improving Outcomes with the 31-GEP Test
    Castle Biosciences
  • 3:40 PM - 4:10 PM ET
    Exhibit Hall Presentation Theater: Head to Head Overall Survival in mCSPC: A Review of Real World Evidence.
    Johnson & Johnson
  • 3:40 PM - 4:25 PM ET
    Exhibit Hall Presentation: Expanding Beyond Binary: Reframing HER2 Expression in mBC
    Daiichi Sankyo, Inc. and AstraZeneca
  • 4:00 PM - 4:30 PM ET
    APSHO Meet & Greet
    APSHO Board of Directors
  • 4:45 PM - 5:45 PM ET
    Multidisciplinary Management of Spinal Metastases: Integrating Surgery and Radiation Therapy
  • 4:45 PM - 5:45 PM ET
    Sequencing Therapies in Non-Hodgkin Lymphomas
  • 4:45 PM - 6:00 PM ET
    Oral Poster Presentations (Part 1)
  • 6:00 PM - 7:00 PM ET
    Independent CE Satellite Symposium: Relapsed/Refractory Multiple Myeloma: Evidence-Based Guidelines and Essential Strategies for Optimized Treatment Selection and Sequencing
  • 7:30 PM - 9:00 PM ET
    Independent CE Dinner Satellite Symposium: Managing HER2 and TROP2 ADC Adverse Events: Advanced Practice Providers Case Discussions Highlighting the Critical Roles in Patient Care
  • Saturday, October 25, 2025
  • 6:30 AM - 5:30 PM ET
    Conference Registration
  • 6:45 AM - 5:00 PM ET
    Exhibitor Registration & Lead Retrieval
  • 7:00 AM - 8:15 AM ET
    Breakfast Activity: Non-CE Satellite Symposium: A Fixed- Duration Treatment Option for 3L+ Diffuse Large B-Cell Lymphoma
    Genentech
  • 7:00 AM - 8:15 AM ET
    Breakfast Activity: Non-CE Satellite Symposium: A Treatment Option for certain patients with Hepatocellular Carcinoma
    Bristol Myers Squibb
  • 7:00 AM - 8:15 AM ET
    Breakfast Activity: Non-CE Satellite Symposium: Treatment Options for Appropriate Patients With Certain Types of Advanced Gynecologic Cancers
    Merck & Co., Inc.
  • 7:00 AM - 8:15 AM ET
    Exhibit Hall Open &
    Continental Breakfast
  • 7:00 AM - 8:15 AM ET
    Professional Profile Pavilion
  • 7:00 AM - 8:15 PM ET
    4 - Breakfast Activity: Non-CE Satellite Symposium: AYVAKIT, The only approved treatment for Indolent Systemic Mastocytosis and Advanced Systemic Mastocytosis
    Blueprint Medicines
  • 8:20 AM - 8:30 AM ET
    Opening Remarks & APSHO FAPO Recognition Presentation
  • 8:30 AM - 8:40 AM ET
    The Annual Mary Pazdur Award Presentation
  • 8:45 AM - 9:15 AM ET
    The Mary Pazdur Award Recipient Lecture
  • 9:25 AM - 10:25 AM ET
    Interpreting Post-Therapeutic Diagnostic Studies
  • 9:25 AM - 10:25 AM ET
    Rebuilding Form and Function: Innovations in Reconstructive Care for the Patient With Cancer
  • 9:25 AM - 10:25 AM ET
    Therapeutic Advances in Metastatic Melanoma: TILs, ImmTACs, and Targeted Therapies
  • 10:00 AM - 4:30 PM ET
    Braindate
  • 10:30 AM - 11:30 AM ET
    Exhibit Hall Open &
    Refreshment Break
  • 10:30 AM - 11:30 AM ET
    Moderated Posters
  • 10:30 AM - 11:30 AM ET
    Professional Profile Pavilion
  • 10:35 AM - 11:05 AM ET
    Exhibit Hall Presentation Theater: EMERALD Study Update: Safety and Efficacy Data in Patients with ER+/HER2-, ESR1-mutated Metastatic Breast Cancer, including Subgroup Analyses
    Stemline, a Menarini Group Company
  • 10:35 AM - 11:05 AM ET
    Exhibit Hall Presentation: The Future of Endocrine Therapy Management: Harnessing Genomics for Better Outcomes
    Agendia
  • 10:35 AM - 11:20 AM ET
    Exhibit Hall Presentation: From Evidence to Action: A Case-Based Approach to Collaborative BCL2-Inhibitor Management in AML
    AbbVie
  • 11:00 AM - 11:30 AM ET
    APSHO Meet & Greet
    Professional & Leadership Development (PD&L) Committee
  • 11:40 AM - 12:40 PM ET
    Advances and Controversies in the Surgical Management of Colorectal Liver Metastases
  • 11:40 AM - 12:40 PM ET
    Evidence-Based Exercise and Diet Strategies Across the Continuum of Cancer Care
  • 11:40 AM - 12:40 PM ET
    Latest Clinical Evidence in Extensive Stage Small Cell Lung Cancer Treatment
  • 12:45 PM - 2:00 PM ET
    Exhibit Hall Open &
    Lunch
  • 12:45 PM - 2:00 PM ET
    Lunch Activity/Non-CE Satellite Symposium: Get the Facts on RYBREVANT™-Based Regimens in EGFR+* Locally Advanced or mNSCLC
    Johnson & Johnson
  • 12:45 PM - 2:00 PM ET
    Lunch Activity/Non-CE Satellite Symposium: Make a Change in cGVHD Treatment Strategy and Provide Rapid, Durable Responses
    Incyte Corporation
  • 12:45 PM - 2:00 PM ET
    Lunch Activity: Non-CE Satellite Symposium: An Exelixis Clinical Presentation on CABOMETYX® (cabozantinib)
    Exelixis
  • 12:45 PM - 2:00 PM ET
    Lunch Activity: Non-CE Satellite Symposium: Biomarker-Directed Treatment Options for ALK-Positive or BRAF V600E–Mutated Metastatic NSCLC
    Pfizer, Inc.
  • 12:45 PM - 2:00 PM ET
    Lunch Activity: Non-CE Satellite Symposium: Myelofibrosis and Strategies for Disease Management: Key Considerations for Patient Care
    GSK
  • 12:45 PM - 2:00 PM ET
    Professional Profile Pavilion
  • 1:00 PM - 1:30 PM ET
    APSHO Meet & Greet
    Membership Committee
  • 1:30 PM - 2:00 PM ET
    APSHO Meet & Greet
    Education Committee
  • 2:05 PM - 2:50 PM ET
    Management of Myelodysplastic Syndromes: Emerging Therapies and Evidence-Based Practice
  • 2:05 PM - 2:50 PM ET
    Targeting More Than Tumors: Applying Pharmacogenomics to Oncology Practice
  • 2:05 PM - 2:50 PM ET
    The Role of Radiation Therapy for Oligometastatic Lung Cancer
  • 3:00 PM - 3:30 PM ET
    APSHO Meet & Greet
    Research & Quality Improvement (RQI) Committee
  • 3:00 PM - 4:15 PM ET
    Exhibit Hall Open &
    Refreshment Break
  • 3:00 PM - 4:15 PM ET
    Professional Profile Pavilion
  • 3:05 PM - 3:35 PM ET
    Exhibit Hall Presentation Theater: Living with Advanced NSCLC*: A Patient’s Treatment Journey
    Regeneron Pharmaceuticals
  • 3:05 PM - 3:35 PM ET
    Exhibit Hall Presentation:
    Peer insights to help identify and manage candidates for treatment with a CDK4/6 inhibitor.© Lilly USA, LLC 2025. All rights reserved.
    Eli Lilly and Company
  • 3:05 PM - 3:45 PM ET
    Exhibit Hall Presentation: Exploring BCL-2i-based Time-Limited Regimens Throughout the CLL Treatment Journey
    AbbVie
  • 3:30 PM - 4:00 PM ET
    APSHO Meet & Greet:
    Radiation Oncology Committee
  • 4:25 PM - 5:25 PM ET
    Beyond the Usual Suspects: Differentiating and Managing Complex Soft-Tissue Tumors
  • 4:25 PM - 5:25 PM ET
    Elevating Your Voice: Empowering Advanced Practitioners in the Insurance Peer-to-Peer Process
  • 4:25 PM - 5:40 PM ET
    New-to-Oncology Roundtables
  • 5:00 PM - 6:30 PM ET
    Independent CE Satellite Symposium: Advancing Care in Genitourinary Cancers: Integrating Targeted Therapies for Metastatic Urothelial Carcinoma and Advanced Prostate Cancer
  • 7:00 PM - 8:30 PM ET
    Independent CE Dinner Satellite Symposium: Ahead of the Immunotherapy Curve in Head and Neck Cancer: Preparing for Expanding Immune Options in Locally Advanced and Recurrent/Metastatic Disease
  • Sunday, October 26, 2025
  • 6:30 AM - 12:00 PM ET
    Registration
  • 7:00 AM - 9:00 AM ET
    Continental Breakfast
  • 7:15 AM - 8:30 AM ET
    Oral Poster Presentations (Part 2)
  • 8:00 AM - 9:15 AM ET
    Breakfast Activity/Non-CE Satellite Symposium: A Nurse’s Guide to Immune Checkpoint Inhibitors in Combination With Select Other Treatment Modalities
    AstraZeneca
  • 8:00 AM - 9:15 AM ET
    Breakfast Activity/Non-CE Satellite Symposium: Patient Case-Based Learning: Clinical Management of Certain Adult Patients With Advanced RCC
    Merck & Co., Inc.
  • 8:00 AM - 9:15 AM ET
    Breakfast Activity/Non-CE Satellite Symposium: Targeted Therapy in mIDH Adult-Type Diffuse Glioma
    Servier Pharmaceuticals
  • 8:15 AM - 9:15 AM ET
    Breakfast Activity/Non-CE Satellite Symposium: APPs in Hematologic Malignancies: Navigating Access to Allogeneic Hematopoietic Stem Cell Transplant
    NMDP
  • 9:20 AM - 10:20 AM ET
    New Drug Updates: Hematologic Malignancies
  • 9:20 AM - 10:20 AM ET
    Speaking Volumes: Inclusive Communication Strategies for Cancer Care in Diverse Populations
  • 10:30 AM - 11:15 AM ET
    Bridging Worlds: Integrating Herbal Knowledge with Conventional Cancer Care
  • 10:30 AM - 11:15 AM ET
    New Frontiers in Neuroendocrine Tumors: Enhancing Diagnosis, Treatment, and Patient Outcomes
  • 11:15 AM - 11:30 AM ET
    Refreshment Break
  • 11:20 AM - 12:20 PM ET
    Mitigating Risk, Maximizing Care: Legal Literacy in Oncology Practice
  • 12:20 PM ET
    Conference Concludes
  • 12:20 PM - 1:50 PM ET
    Post Conference: Independent CE Lunch Satellite Symposium:
    Antibody–Drug Conjugates in Oncology: The Essentials of AE Management for Better Patient Outcomes